Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort

Read original: arXiv:2409.01330 - Published 9/4/2024 by Iulian Emil Tampu, Per Nyman, Christoforos Spyretos, Ida Blystad, Alia Shamikh, Gabriela Prochazka, Teresita D'iaz de St{aa}hl, Johanna Sandgren, Peter Lundberg, Neda Haj-Hosseini
Total Score

0

Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Researchers evaluate state-of-the-art deep learning methods for classifying pediatric brain tumors using digital histopathology images.
  • The study is conducted on a multi-center Swedish cohort, assessing the performance of these methods in a real-world clinical setting.
  • The findings provide insights into the feasibility and potential of using deep learning for automated brain tumor diagnosis.

Plain English Explanation

The provided paper [^1] investigates the use of deep learning, a form of artificial intelligence, to classify different types of pediatric brain tumors. Brain tumors are abnormal growths in the brain, and correctly identifying their type is crucial for proper treatment.

In this study, the researchers evaluated several state-of-the-art deep learning methods on a dataset of digital histopathology images, which are microscopic images of tumor tissue samples. The dataset was collected from multiple medical centers in Sweden, representing a diverse, real-world clinical setting.

The deep learning models were trained to analyze the images and automatically determine the type of brain tumor present. This could potentially assist doctors in making more accurate and efficient diagnoses, leading to better patient outcomes.

The researchers found that the deep learning methods were able to achieve promising results in classifying the brain tumors. This suggests that these AI-based techniques could be a valuable tool for supporting clinicians in the diagnosis and management of pediatric brain tumors.

[^1]: Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort

Technical Explanation

The paper [^1] evaluates the performance of state-of-the-art deep learning methods for classifying pediatric brain tumors using digital histopathology images. The researchers used a dataset collected from multiple medical centers in Sweden, which includes a diverse range of brain tumor types and demographics.

The study compared the performance of several deep learning architectures, including convolutional neural networks (CNNs) and transformer-based models, on the task of brain tumor classification. The models were trained to analyze the histopathology images and predict the specific type of brain tumor present.

To assess the models' performance, the researchers used various metrics, such as accuracy, precision, recall, and F1-score. The results showed that the deep learning methods were able to achieve promising classification accuracy, demonstrating the potential of these AI-based techniques for automated brain tumor diagnosis.

The study also highlighted the importance of evaluating deep learning models in a real-world, multi-center setting, as this can provide valuable insights into the models' robustness and generalizability. The findings from this research can inform the further development and deployment of deep learning-based tools for supporting clinicians in the management of pediatric brain tumors.

[^1]: Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort

Critical Analysis

The paper [^1] presents a thorough evaluation of state-of-the-art deep learning methods for classifying pediatric brain tumors using digital histopathology images. The authors acknowledge several limitations and areas for further research:

  • The dataset, while diverse, may not fully represent the entire spectrum of pediatric brain tumor cases seen in clinical practice. Expanding the dataset to include more rare tumor types could further test the models' generalization capabilities.
  • The study focused on tumor classification, but additional functionalities, such as tumor segmentation and prognostic prediction, could be valuable for clinical decision-making and should be explored in future research.
  • The interpretability of the deep learning models' decision-making process is not thoroughly discussed. Incorporating explainable AI techniques could enhance the models' transparency and trust in their predictions.
  • The long-term clinical impact and cost-effectiveness of integrating these deep learning-based tools into routine clinical workflows should be assessed through larger-scale, real-world deployment and longitudinal studies.

Overall, the findings from this paper [^1] are promising and contribute to the growing body of research on the potential of deep learning for supporting clinical decision-making in pediatric brain tumor diagnosis. However, continued advancements and collaborative efforts between researchers and clinicians are necessary to translate these methods into practical, reliable, and widely adopted tools in the field.

[^1]: Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort

Conclusion

The paper [^1] presents a comprehensive evaluation of state-of-the-art deep learning methods for classifying pediatric brain tumors using digital histopathology images. The study was conducted on a diverse, multi-center Swedish dataset, providing valuable insights into the performance of these AI-based techniques in a real-world clinical setting.

The findings suggest that deep learning holds great promise for automated brain tumor diagnosis, with the potential to assist clinicians in making more accurate and efficient decisions. However, the authors also highlight the need for further research to address limitations, such as dataset diversity, model interpretability, and long-term clinical impact.

Overall, this study [^1] contributes to the growing body of evidence supporting the integration of deep learning technologies into the field of pediatric brain tumor diagnosis and management. Continued advancements in this area could lead to improved patient outcomes and more efficient healthcare delivery.

[^1]: Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort
Total Score

0

Pediatric brain tumor classification using digital histopathology and deep learning: evaluation of SOTA methods on a multi-center Swedish cohort

Iulian Emil Tampu, Per Nyman, Christoforos Spyretos, Ida Blystad, Alia Shamikh, Gabriela Prochazka, Teresita D'iaz de St{aa}hl, Johanna Sandgren, Peter Lundberg, Neda Haj-Hosseini

Brain tumors are the most common solid tumors in children and young adults, but the scarcity of large histopathology datasets has limited the application of computational pathology in this group. This study implements two weakly supervised multiple-instance learning (MIL) approaches on patch-features obtained from state-of-the-art histology-specific foundation models to classify pediatric brain tumors in hematoxylin and eosin whole slide images (WSIs) from a multi-center Swedish cohort. WSIs from 540 subjects (age 8.5$pm$4.9 years) diagnosed with brain tumor were gathered from the six Swedish university hospitals. Instance (patch)-level features were obtained from WSIs using three pre-trained feature extractors: ResNet50, UNI and CONCH. Instances were aggregated using attention-based MIL (ABMIL) or clustering-constrained attention MIL (CLAM) for patient-level classification. Models were evaluated on three classification tasks based on the hierarchical classification of pediatric brain tumors: tumor category, family and type. Model generalization was assessed by training on data from two of the centers and testing on data from four other centers. Model interpretability was evaluated through attention-mapping. The highest classification performance was achieved using UNI features and AMBIL aggregation, with Matthew's correlation coefficient of 0.86$pm$0.04, 0.63$pm$0.04, and 0.53$pm$0.05, for tumor category, family and type classification, respectively. When evaluating generalization, models utilizing UNI and CONCH features outperformed those using ResNet50. However, the drop in performance from the in-site to out-of-site testing was similar across feature extractors. These results show the potential of state-of-the-art computational pathology methods in diagnosing pediatric brain tumors at different hierarchical levels with fair generalizability on a multi-center national dataset.

Read more

9/4/2024

BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions
Total Score

0

BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions

Spyridon Bakas, Siddhesh P. Thakur, Shahriar Faghani, Mana Moassefi, Ujjwal Baid, Verena Chung, Sarthak Pati, Shubham Innani, Bhakti Baheti, Jake Albrecht, Alexandros Karargyris, Hasan Kassem, MacLean P. Nasrallah, Jared T. Ahrendsen, Valeria Barresi, Maria A. Gubbiotti, Giselle Y. L'opez, Calixto-Hope G. Lucas, Michael L. Miller, Lee A. D. Cooper, Jason T. Huse, William R. Bell

Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detecting various morpho-pathological features of distinct histology throughout digitized tissue sections is crucial. Such features include the presence of cellular tumor, geographic necrosis, pseudopalisading necrosis, areas abundant in microvascular proliferation, infiltration into the cortex, wide extension in subcortical white matter, leptomeningeal infiltration, regions dense with macrophages, and the presence of perivascular or scattered lymphocytes. With these features in mind and building upon the main aim of the BraTS Cluster of Challenges https://www.synapse.org/brats2024, the goal of the BraTS-Path challenge is to provide a systematically prepared comprehensive dataset and a benchmarking environment to develop and fairly compare deep-learning models capable of identifying tumor sub-regions of distinct histologic profile. These models aim to further our understanding of the disease and assist in the diagnosis and grading of conditions in a consistent manner.

Read more

5/20/2024

🤖

Total Score

0

The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)

Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Deep Gandhi, Zhifan Jiang, Syed Muhammed Anwar, Jake Albrecht, Maruf Adewole, Udunna Anazodo, Hannah Anderson, Ujjwal Baid, Timothy Bergquist, Austin J. Borja, Evan Calabrese, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Ariana Familiar, Keyvan Farahani, Andrea Franson, Anurag Gottipati, Shuvanjan Haldar, Juan Eugenio Iglesias, Anastasia Janas, Elaine Johansen, Blaise V Jones, Neda Khalili, Florian Kofler, Dominic LaBella, Hollie Anne Lai, Koen Van Leemput, Hongwei Bran Li, Nazanin Maleki, Aaron S McAllister, Zeke Meier, Bjoern Menze, Ahmed W Moawad, Khanak K Nandolia, Julija Pavaine, Marie Piraud, Tina Poussaint, Sanjay P Prabhu, Zachary Reitman, Jeffrey D Rudie, Mariana Sanchez-Montano, Ibraheem Salman Shaikh, Nakul Sheth, Wenxin Tu, Chunhao Wang, Jeffrey B Ware, Benedikt Wiestler, Anna Zapaishchykova, Miriam Bornhorst, Michelle Deutsch, Maryam Fouladi, Margot Lazow, Leonie Mikael, Trent Hummel, Benjamin Kann, Peter de Blank, Lindsey Hoffman, Mariam Aboian, Ali Nabavizadeh, Roger Packer, Spyridon Bakas, Adam Resnick, Brian Rood, Arastoo Vossough, Marius George Linguraru

Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. Here we present the CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge, focused on pediatric brain tumors with data acquired across multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. The CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge brings together clinicians and AI/imaging scientists to lead to faster development of automated segmentation techniques that could benefit clinical trials, and ultimately the care of children with brain tumors.

Read more

7/15/2024

🗣️

Total Score

0

Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review

Jan-Philipp Redlich, Friedrich Feuerhake, Joachim Weis, Nadine S. Schaadt, Sarah Teuber-Hanselmann, Christoph Buck, Sabine Luttmann, Andrea Eberle, Stefan Nikolin, Arno Appenzeller, Andreas Portmann, Andr'e Homeyer

In recent years, the diagnosis of gliomas has become increasingly complex. Analysis of glioma histopathology images using artificial intelligence (AI) offers new opportunities to support diagnosis and outcome prediction. To give an overview of the current state of research, this review examines 83 publicly available research studies that have proposed AI-based methods for whole-slide histopathology images of human gliomas, covering the diagnostic tasks of subtyping (23/83), grading (27/83), molecular marker prediction (20/83), and survival prediction (29/83). All studies were reviewed with regard to methodological aspects as well as clinical applicability. It was found that the focus of current research is the assessment of hematoxylin and eosin-stained tissue sections of adult-type diffuse gliomas. The majority of studies (52/83) are based on the publicly available glioblastoma and low-grade glioma datasets from The Cancer Genome Atlas (TCGA) and only a few studies employed other datasets in isolation (16/83) or in addition to the TCGA datasets (15/83). Current approaches mostly rely on convolutional neural networks (63/83) for analyzing tissue at 20x magnification (35/83). A new field of research is the integration of clinical data, omics data, or magnetic resonance imaging (29/83). So far, AI-based methods have achieved promising results, but are not yet used in real clinical settings. Future work should focus on the independent validation of methods on larger, multi-site datasets with high-quality and up-to-date clinical and molecular pathology annotations to demonstrate routine applicability.

Read more

7/15/2024